Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
5.71
-0.79 (-12.10%)
Dec 3, 2024, 1:43 PM EST - Market open
Kyverna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 246 | - | - | - |
| Enterprise Value | -32 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.18 | 0.23 | 0.09 |
| Asset Turnover | - | - | 0.09 | - |
| Quick Ratio | 10.38 | 2.90 | 4.29 | 4.78 |
| Current Ratio | 10.50 | 3.05 | 4.45 | 4.84 |
| Return on Equity (ROE) | -59.58% | -125.95% | -52.95% | - |
| Return on Assets (ROA) | -35.60% | -54.89% | -24.10% | - |
| Return on Capital (ROIC) | -39.38% | -67.54% | -29.32% | - |
| Buyback Yield / Dilution | -5987.19% | -47.89% | -71.30% | - |
| Total Shareholder Return | -5987.19% | -47.89% | -71.30% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.